Literature DB >> 21567429

Human T cell lymphotropic virus type 1 (HTLV-1) proviral load of HTLV-associated myelopathy/tropical spastic paraparesis (HAM/TSP) patients according to new diagnostic criteria of HAM/TSP.

Maria Fernanda Rios Grassi1, Viviana Nilla Olavarria, Ramon de Almeida Kruschewsky, Rita Elizabeth Mascarenhas, Inês Dourado, Luis C L Correia, Carlos Maurício de Castro-Costa, Bernardo Galvão-Castro.   

Abstract

A high human T-cell lymphotropic virus type 1 (HTLV-1) proviral load is described in HTLV-1-associated diseases, especially HAM/TSP. However, the cut-off value to define high levels of HTLV-1 proviral load is not well established. 281 HTLV-1-infected patients from the HTLV reference center in Salvador, Brazil, were followed from 2005 to 2008. Patients were classified as asymptomatic, possible-, probable-, and definite-HAM/TSP, in accordance with diagnostic criteria proposed by De Castro-Costa et al. (2006): AIDS Res Hum Retroviruses 22:931-935. HTLV-1 proviral load was determined using real-time PCR. A receiver operator characteristic (ROC) curve was constructed using only asymptomatic individuals and definite-HAM/TSP patients. The ROC curve was used to predict the proviral load level that differentiates these two groups. Out of 281 patients, 189 were asymptomatic and 92 were diagnosed with HAM/TSP (22 possible, 23 probable, 47 definite). The mean HTLV-1 proviral load was higher in possible- (89,104 ± 93,006 copies/106 PBMC), -probable (175,854 ± 128,083 copies/106 PBMC), and definite-HAM/TSP patients (150,667 ± 122,320 copies/106 PBMC),when compared to asymptomatic individuals (27,178 ± 41,155 copies/106 PBMC) (P < 0.0001). A comparison of all HAM/TSP groups showed the highest proviral loads in probable-HAM/TSP patients, yet the differences in mean values were not statistically significant. The ROC curve suggested a value of 49,865 copies/106 PBMC, with 87% sensitivity (95% CI ¼ 74-95) and 81% specificity (95% CI ¼ 75-86), as the best proviral load cut-off point to differentiate definite HAM/TSP patients from asymptomatic individuals. HTLV-1 proviral loads are higher in groups of infected patients with eurological symptoms and may represent a relevant biological marker of disease progression.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21567429     DOI: 10.1002/jmv.22087

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  28 in total

1.  Soluble IL-2 receptor and beta-2 microglobulin as possible serologic markers of neurologic disease in HTLV-1 infection.

Authors:  Cristina Toledo-Cornell; Silvane Santos; Gloria Orge; Marshall J Glesby; Edgar M Carvalho
Journal:  J Med Virol       Date:  2013-09-11       Impact factor: 2.327

2.  Immunological and viral features in patients with overactive bladder associated with human T-cell lymphotropic virus type 1 infection.

Authors:  Silvane Braga Santos; Paulo Oliveira; Tania Luna; Anselmo Souza; Márcia Nascimento; Isadora Siqueira; Davi Tanajura; André Luiz Muniz; Marshall J Glesby; Edgar M Carvalho
Journal:  J Med Virol       Date:  2012-11       Impact factor: 2.327

3.  Neurological Manifestations in Human T-Cell Lymphotropic Virus Type 1 (HTLV-1)-Infected Individuals Without HTLV-1-Associated Myelopathy/Tropical Spastic Paraparesis: A Longitudinal Cohort Study.

Authors:  Davi Tanajura; Néviton Castro; Paulo Oliveira; Abraão Neto; André Muniz; Natália B Carvalho; Glória Orge; Silvane Santos; Marshall J Glesby; Edgar M Carvalho
Journal:  Clin Infect Dis       Date:  2015-03-27       Impact factor: 9.079

4.  Differential effects of HTLV-1 Tax oncoprotein on the different estrogen-induced-ER α-mediated transcriptional activities.

Authors:  Ammar Abou-Kandil; Nora Eisa; Azhar Jabareen; Mahmoud Huleihel
Journal:  Cell Cycle       Date:  2016-07-15       Impact factor: 4.534

5.  Association between HLA alleles and HAM/TSP in individuals infected with HTLV-1.

Authors:  Ana Treviño; Jose L Vicario; Mariola Lopez; Patricia Parra; Rafael Benito; Raul Ortiz de Lejarazu; Jose M Ramos; Jorge Del Romero; Carmen de Mendoza; Vincent Soriano
Journal:  J Neurol       Date:  2013-07-09       Impact factor: 4.849

Review 6.  Clinical and Public Health Implications of Human T-Lymphotropic Virus Type 1 Infection.

Authors:  Nicolas Legrand; Skye McGregor; Rowena Bull; Sahar Bajis; Braulio Mark Valencia; Amrita Ronnachit; Lloyd Einsiedel; Antoine Gessain; John Kaldor; Marianne Martinello
Journal:  Clin Microbiol Rev       Date:  2022-02-23       Impact factor: 50.129

7.  Utility of HTLV proviral load quantification in diagnosis of HTLV-1-associated myelopathy requires international standardization.

Authors:  Maria Fernanda Rios Grassi; Viviana Nilla Olavarria; Ramon de Almeida Kruschewsky; Yoshihisa Yamano; Steven Jacobson; Graham P Taylor; Fabiola Martin; Bernardo Galvão-Castro
Journal:  J Clin Virol       Date:  2013-09-13       Impact factor: 3.168

8.  A 17-Year-Old Boy With Right Face Palsy, Left Leg Weakness, and Lytic Skull-Bone Lesions.

Authors:  Ibukunoluwa C Akinboyo; Genevieve M Crane; Lingling Chen; Ravit Arav-Boger
Journal:  J Pediatric Infect Dis Soc       Date:  2018-12-03       Impact factor: 3.164

9.  Conference highlights of the 15th International Conference on Human Retrovirology: HTLV and related retroviruses, 4-8 June 2011, Leuven, Gembloux, Belgium.

Authors:  Fabiola Martin; Charles R M Bangham; Vincenzo Ciminale; Michael D Lairmore; Edward L Murphy; William M Switzer; Renaud Mahieux
Journal:  Retrovirology       Date:  2011-10-28       Impact factor: 4.602

10.  Molecular characterization of HTLV-1 gp46 glycoprotein from health carriers and HAM/TSP infected individuals.

Authors:  Aline C A Mota-Miranda; Fernanda K Barreto; Maria F C Amarante; Everton Batista; Joana P Monteiro-Cunha; Lourdes Farre; Bernardo Galvão-Castro; Luiz C J Alcantara
Journal:  Virol J       Date:  2013-03-06       Impact factor: 4.099

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.